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Influence of reducing luxury calories in the treatment of experimental
mammary carcinoma
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Summary The aim of this study was to investigate the influence of dietary calorie intake at three different fat
levels on (a) the growth of established methylnitrosourea (MNU)-induced mammary carcinoma, (b) the
reappearance of mammary carcinomas after surgical removal, and (c) the growth of manifest lesions in
animals treated with the cytostatic agent hexadecylphosphocholine (HPC). A reduction of calories by 30%
significantly inhibited tumour growth of manifest mammary carcinomas in rats, without having a negative
influence on body weight gain. After chemotherapeutic treatment no significant dietary influence was observed
besides the high antineoplastic efficacy of HPC, but when feeding calorically restricted diets to surgically
treated animals the number of reappearing tumours was considerably smaller (P = 0.06) than after feeding the
diets ad libitum. The fat content of the diets did not influence the growth of manifest mammary carcinomas.
No significant dietary effects were exerted on oestradiol or testosterone levels in untreated tumour bearing
animals. An elevation of oestradiol levels was observed when animals were subjected to HPC and fed a high
calorie diet. An elevation of testosterone levels was assessed after surgical treatment of the rats, irrespective of
fat content and calorie level. Our results suggest that a reduction of calories can inhibit growth of manifest
mammary carcinomas and has impeding effects on tumour development after surgical removal. After effective
chemotherapeutic treatment the additional influence ofdietary changes was of less relevance. Furthermore, our
data do not establish any association between growth inhibition of mammary tumours, caused by the mild
caloric restriction, and altered oestradiol or testosterone production.
'It is an unfortunate accident of history that ad lib feeding is
regarded as the norm for laboratory rats and mice.' 'It is
now overdue that restricted feeding be regarded as the norm
and as more scientific.' Roe (1981)
The relationship between breast cancer and dietary fat and/or
calorie intake has been investigated in many epidemiological
and experimental animal studies (Howe et al., 1990; Hulka
1989; McCormick 1989; Welsch 1987). Both epidemiological
and experimental data remain inconsistent concerning the
influence of dietary fat or calorie consumption on mammary
tumourigenesis. Although several epidemiological studies
support the hypothesis of a breast cancer-fat association
(Hirayama 1978; Hislop et al., 1986; Hursting et al., 1990;
Lubin et al., 1986; Phillips & Snowdon, 1983; Schatzkin et
al., 1989; Van't Veer et al., 1990) other studies indicate that
dietary factors beside fat play a greater role in the genesis of
breast cancer (Graham et al., 1982, Hirohata et al., 1987;
Jones et al., 1987; Mills et al., 1988; Rosen et al., 1988, Willet
et al., 1987). Data obtained in various experimental animal
models are likewise not unanimous concerning the dietary
influence of fat intake on chemically induced mammary car-
cinogenesis. High dietary fat or different types of fatty acids
are reported to influence mammary tumourigenesis in ani-
mals (Apgar & Shively 1990; Caroll & Khor, 1971; Clinton et
al., 1988; Hopkins et al., 1981; Ip & Ip, 1980; Kumaki &
Noguchi, 1990; Lasekan et al., 1990; Sundram et al., 1989;
Welsch et al., 1990). In addition, mammary carcinogenesis
was described as a function of calorie intake (Beth et al.,
1987; Engelmann et al., 1990; Klurfeld et al., 1989; Kritchev-
sky et al., 1989, Shao et al., 1990). Angres and Beth (1991)
analysed results of animal experiments, published from 1975
to 1985, concerning dietary influences on chemically induced
mammary carcinogenesis. This literature survey confirmed
the inconsistency of the data obtained so far, except for the
uniform effect of calories.
The study presented here wants to deal with another aspect
that has not been investigated thoroughly. We focused our
attention on the time period following the appearance of
mammary tumours in order to answer the following ques-
tions: Does a change of dietary fat or calorie intake have any
influence (1) on the growth of manifest methylnitrosourea
(MNU)-induced mammary tumours, (2) on the regrowth of
mammary carcinomas after surgical removal, and (3) on the
growth of manifest mammary carcinomas in animals treated
with the new cytostatic agent hexadecylphosphocholine
(HPC)? The latter two questions imply the question whether
dietary means might have any impact on commonly used
clinical treatment of breast cancer.
Biochemical mechanisms responsible for dietary effects in
mammary carcinogenesis have only poorly been elucidated
(Cave & Hilf, 1987; Welsch, 1987). Direct effects of fat on
tumour development (e.g. changes in the lipid content of the
cell membrane and/or synthesis of prostaglandins) and in-
direct effects on host metabolism such as alterations in the
endocrine milieu are under discussion (Cohen, 1981). Hor-
mones such as insulin (Feldman & Hilf, 1985; Hilf, 1982),
thyroid hormone status (Cave et al., 1977; Vonderhaar,
1982), glucocorticoids (Aylsworth et al., 1980; Nakamura et
al., 1981), prolactin (Aylsworth et al., 1984; Ip et al., 1980),
progesterone (Danguy et al., 1980; Yoshida et al., 1980), as
well as oestrogens (Williams & Dickerson, 1987) were des-
cribed to play a role in the development of breast cancer.
Therefore the dietary influence after tumour manifestation on
oestradiol and testosterone, two hormones which are in-
volved in reproduction, was studied additionally.
Materials and methods
Animals and housing
Two hundred and forty female Sprague-Dawley rats were
purchased from the Zentralinstitut fur Versuchstierzucht,
Hannover, at the age of 40 days. They were kept under
conventional conditions at a constant room temperature of
22-23°C with a circadian light rhythm of 12 h and were
housed one rat per cage.
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Chemicals and hormone assays
Hexadecylphosphocholine (HPC) (Figure 1) was obtained
from Asta Pharma, Frankfurt. Methylnitrosourea (MNU)
was obtained from Prof Dr M. Wiessler, Institute of Tox-
icology and Chemotherapy, German Cancer Research
Center, Heidelberg.
The oestradiol assay kit with anti-oestradiol antibodies
derived from rabbit (DELFIA Estradiol kit, time-resolved
fluoroimmunoassay kit 1244-043) was supplied by Baxter
(Travenol) GmbH, Unterschleissheim and the testosterone
assay kit (a solid phase radioimmunoassay, Coat-A-count
(J-125)) with testosterone antibodies derived from rabbit by
Diagnostic Product Corporation (Vertrieb Hermann Bier-
mann, Bad Nauheim). The within-assay variability and the
within- and between-assay variabilities were < 10%.
Tumour induction
On day 50 of life all animals were injected with 25 mg kg-'
MNU via the tail vein to induce mammary carcinomas.
Diets,feeding and treatment
Prior to tumour induction with MNU all animals were fed a
standard commercial diet (Altromin 1320, Lage, FRG). One
day after tumour induction the animals received a diet con-
taining 45 energy % fat at an energy level (50 kcal day-')
considered equivalent to 'ad libitum' feeding. This diet was
administered for 18 ± 4 weeks until an individual tumour size
of 1 cm3 had been reached. One hundred and ninety-four rats
with this total tumour volume were then randomly divided
into the following groups: Group 1: control group (CO):
Animals of this group were fed diets containing 45 en%, 35
en% and 25 en% fat at 50 kcal per day or restricted at
35 kcal per day ( = six subgroups). The latter choice level was
sufficient for maintaining the body weight of adult rats and
the difference between both calorie levels is termed 'luxury
calories' hereafter. Group 2: Surgically treated group (OP):
All animals were fed diets as indicated above following sur-
gical removal of all palpable mammary tumours ( = six subg-
roups). Group 3: Chemotherapeutically treated group (HPC):
All rats received the same diets as the animals of the control
group and in addition were treated with 100 mgkg-' HPC
intragastrically once a week for 5 weeks (= six subgroups).
The duration of feeding these diets was 10 ± 2 weeks.
Thereafter the experiment was terminated. The composition
of the diets which were obtained from Unilever Research,
Rotterdam, The Netherlands, is shown in Table I and the
profile of dietary acids is shown in Table II. The effective
number of animals in each group is shown in Table III. The
fatty acid composition of the diets reflected the fatty acid
profile of the normal West German diet (normal diet = ND).
All diets were kept frozen at - 20°C to minimise lipid perox-
idation and were thawed before feeding. All rats received tap
water ad libitum.
Evaluation ofbody weight and tumour growth
Body weight, occurrence, number and size of tumours were
recorded weekly until the end of the experiment. The tumour
size was evaluated by measuring two perpendicular axes with
Vernier calipers according to the formula a2 x b/2 (a< b).
The mean tumour volume was calculated from the tumour
volumes in individual animals. At the end of the experiment
all animals were killed after blood sampling under ether
O CH3
II I + H3C - (CH2))5-O- P-O - (CH2)2-N - CH3
°0 -CH3
Figure 1 Chemical formula of the cytostatic agent hexadecyl-
phosphocholine (HPC), a compound of the group of ether-lipids.
Table I Composition ofdiets
Diet ND25a ND35 ND45
Composition: g 100 g'
Protein 23.90 25.70 27.70
Carbohydrate 57.20 49.80 40.90
Fat 10.40 15.60 21.60
Cellulose 5.80 6.20 6.70
Minerals 2.08 2.24 2.42
Vitamins 0.39 0.41 0.44
Protein (en %)b 24.00 24.00 24.00
Carbohydrate (en %)b 51.00 41.00 31.00
Fat (en %)b 25.00 35.00 45.00
Cellulose (mg kcal ') 15.00 15.00 15.00
Minerals (mg kcal ') 5.40 5.40 5.40
Vitamins (mg kcal ') 1.00 1.00 1.00
aND = normal diet, ben%: Percentage of total energy.
Table II Profile ofdietary fatty acids
Diet (energy %)b
Fatty acids Weight %a ND25 ND35 ND45
C <14:0 0.1 0.0 0.0 0.0
C 14:0 1.2 0.3 0.4 0.5
C 16:0 37.7 9.4 13.2 17.0
C 16:1 0.6 0.1 0.2 0.2
C 16:2 0.1 0.0 0.0 0.0
C 17:0 0.2 0.0 0.1 0.1
C 18:0 5.7 1.4 2.0 2.6
C 18:1 36.4 9.1 12.7 16.4
C 18:2 15.8 3.9 5.5 7.1
C 18:3 0.1 0.0 0.0 0.0
C 20:0 0.6 0.1 0.2 0.2
C 20:1 0.6 0.2 0.2 0.3
C 20:2 0.2 0.1 0.1 0.1
C 21:0 0.1 0.0 0.0 0.0
C 22:0 0.2 0.1 0.1 0.1
C 22:2 0.1 0.0 0.0 0.0
Total sum 99.7 24.9 34.8 44.8
Fat content (weight %): 10.4 15.6 21.6
Sunflower seed oil 11%
Lard 14%
Palm oil 75%
100
aPercentage of total weight. bPercentage of total energy.
anaesthesia. All tumours were excised, weighed and in part
fixed in 10% buffered formalin for histological examination
(Prof D. Komitowsky, Institute of Pathology, German
Cancer Research Center). Organs with macroscopically visi-
ble changes were fixed in formalin as well and examined
histologically. The correlation of tumour volume, measured
at the end of study, and of tumour weight determined at
necropsy was highly significant (P<0.01) with r = 0.86 for
the equation of linear regression y = 0.95x-0.06.
Proceduresfor measuring oestradiol and testosterone
Before termination of the experiment vaginal smears were
taken daily to monitor the oestrous cycle. When an animal
reached the stage ofdioestrus blood was taken from the vena
cava inferior at 12.00 a.m., plasma was separated from the
heparinised blood samples, frozen at - 80°C and subse-
quently analysed for oestradiol and testosterone concentra-
tions.
Statistical analysis
Mean values of body weight, tumour number and tumour
volume were used to tabulate the data. Analyses of these
parameters were performed using a non-parametric mul-
tivariate test (Koziol & Donna, 1981). A two way analysis of
variance with interactions yielded that there were no interac-
tions present between fat levels and amount of calories. This
justified the pooling of the groups for an individual analysisLUXURY CALORIES AND MAMMARY CARCINOMA 847
Table III Influence ofdifferent fatty diets and caloric levels on mean body weights
and on mortality in rats bearing MNU-induced mammary carcinomas
Mean body weight (g) Mortality
Diet (kcald-') na Week 1P Week 6h Week jjh,i (%)
Group 1 NDb45-5Okcal d' 13 286(10) 299(14)C 286(15)d 15.4
(CO) ND45-35kcald-' 12 280(12) 275 (l)b 275(27) 0.0
ND35-50 kcal d- 11 270(24) 288(26) 292(24)d 18.2
ND35-35 kcal d-' 10 270(20) 265(15) 272(17) 10.0
ND25-50kcal d-' 8 273(11) 291(14) 284(18)d 0.0
ND25-35 kcal d' 11 280(14) 281(14) 277(15) 0.0
Group 2 ND45-50 kcal d-' 11 280 (8) 282(16) 297(14)C 0.0
(OP) ND45-35 kcal d' 10 273(10) 266(10) 267 (8) 0.0
ND35-50 kcal d-' 12 283(13) 277(14) 300(24)C 0.0
ND35-35 kcal d-' 10 297(28) 268(14) 271 (6) 0.0
ND25-50 kcal d-' 9 275 (7) 301 (9) 309(19)C 0.0
ND25-35 kcal d-' 10 278(14) 278(14) 280(13) 0.0
Group 3 ND45-50 kcal d' 12 276(13) 273 (9) 301(18)f 0.0
(HPC) ND45-35 kcal d' 7 277 (8) 262(18) 266(17) 0.0
ND35-S0kcal d-' 13 272(14) 280(11) 302(17)f 0.0
ND35-35 kcal d-' 9 281(15) 273(22) 267(29) 0.0
ND25-50 kcal d' 18 279(10) 265 (9) 294 (8)f 0.0
ND25-35 kcal d-' 8 282(12) 267(12) 271(11) 12.5
an = Numberofanimalsatterminationofstudy, bND = normal-Diet, percentage of
total energy: 45%, 35%, 25%, 'mean (standard deviation), dp = 0.001, ,'p<O.O ,
significantdifferencebetweenthebodyweightsofallhighcaloricgroupsversusall low
caloric groups (Koziol & Donna test), gtime of dietary change, hweeks after dietary
change, itermination ofexperiment,imortality due to technical failures were excluded
from evaluation.
of fat and calorie effects. The recurrence rates of tumours
after surgical removal in the respective groups were com-
pared by Fisher's exact test (Sachs, 1983). Comparisons of
the parameters of oestradiol and testosterone between the
groups were made by the Wilcoxon rank sum test (single
comparison) or Kruskal Wallis test (multiple comparisons)
(Hollander & Wolfe, 1973).
Results
Body weight
The influence of different fatty diets at two caloric levels on
the mean body weight of untreated tumour-bearing animals
(control group) is shown in Table III. All groups receiving
their diets at a caloric level of 50 kcal per day showed
significantly (P = 0.001, multivariate test; test statistics =
13.63) higher body weight gain than rats receiving 35 kcal per
day. The restrictively fed groups, however, had no loss of
body weight, but kept their mean body weight over the whole
experimental period (compare weeks 6 and 11, Table III).
Surgically treated groups of animals (Group 2 - OP) exhi-
bited similar body weight developments (Table III). Feeding
50 kcal per day produced higher weight gain than feeding
35 kcap per day, but the reduced feeding was not followed by
a loss of body weight. After chemotherapeutically treating
the rats with HPC (Group 3 - HPC), a slight decrease in
body weight was observed during the 5-week period of treat-
ment, both for the high- and the low-calorie groups (Table
III). While the high calorie groups had an increase in body
weight after the end of treatment with the cytostatic agent,
the body weight of restrictively fed groups remained stable.
Since the initial weight loss did not exceed 10% of the body
weight, it had no influence on tumour development. Dietary
fat levels did not significantly influence body weight.
Mortality
In untreated tumour-bearing animals as well as in surgically
or chemotherapeutically treated animals mortality was not
related to the concentration of fat or to the level of calories
in the diet (Table III).
Tumour growth and histology
Dietary influences on tumour growth development in untrea-
ted tumour-bearing animals (CO) are shown in Table IV.
Administration of the diets ND45, ND35 and ND25 at
50 kcal day-' produced greater tumour volumes than feeding
the same fat concentrations at 35 kcal day-'. This difference
proved to be significant (P = 0.01, multivariate test; test
statistics = 8.95) when the tumour volumes of all low-calorie
groups were compared with those of all high-calorie groups
irrespective of the fat level. After surgical treatment (OP)
feeding of calorically restricted diets (ND45, ND35 and
ND25) produced smaller tumour volumes than feeding of
diets ad libitum (50 kcal d-'). The observed difference be-
tween the two caloric levels failed to be significant. Tumour
growth development of chemotherapeutically treated animals
was effectively inhibited by HPC and remained very close to
the detection limit even following the end of treatment; there
were no significant differences between the two calorie levels.
When the different fat concentrations were compared among
all groups, irrespective of the calorie levels neither the control
group nor the surgically or chemotherapeutically treated
groups showed significant differences in tumour volumes. The
histological examination of mammary tumours yielded
adenocarcinomas in 94% and adenomas in 6%, irrespective
of the dietary groups.
Tumour number
Corresponding to the development of the mean tumour
volume, administration of all diets at 50 kcal produced
significantly (P = 0.04, multivariate test; test statistics = 6.24)
higher tumour numbers than feeding of 35 kcal in untreated
tumour-bearing animals. Following surgical or chemothera-
peutic treatment, administration of all diets did not cause
significant differences in tumour numbers between the two
caloric levels (Table IV), although the difference between the
two caloric levels after surgical treatment was very close to
the level of significance (P = 0.06, multivariate test; test
statistics = 5.61). Comparison of the different fat levels, irre-
spective of the caloric levels, did not yield any significant
differences.848 B. BUNK et al.
TableIV Influenceofdifferentfattydietsandcaloriclevelsonmeantumourvolumes
and mean tumour numbers in rats bearing MNU-induced mammary carcinomas
Mean tumour volume (cm) Mean tumor
Diet (kcald-') na Week 18 Week6h Week II'- nwnberi
Group 1 NDb45-50kcald- 13 1.8(0.8) 6.3(4.1)c 7.5(5.3)d 2.7(0.9)e
(CO) ND45-35 kcal d- 12 1.6(0.8) 4.7(6.1) 1.6(1.9) 1.5(0.6)
ND35-50 kcal d-i 11 1.1(0.4) 4.8(4.2) 6.2(5.2)d 2.4(0.9)e
ND35-35 kcal d-' 10 1.8(1.0) 5.8(5.1) 1.9(1.8) 1.3(0.5)
ND25-50 kcal d' 8 1.8(1.3) 4.7(2.6) 4.3(3.6)d 2.2(0.7)e
ND25-35 kcal d 11 1.6(0.6) 3.7(2.6) 2.8(3.5) 1.8(0.6)
Group 2 ND45-50 kcal d-' 11 0 1.2(2.7) 2.0(2.9) 1.7(0.9)f
(OP) ND45-35 kcal d-' 10 0 0.7(2.1) 0.3(0.7) 0.9(0.6)
ND35-50 kcal d' 12 0 2.7(6.6) 5.1(4.4) 1.8(0.9)f
ND35-35 kcal d' 10 0 2.2(3.4) 2.7(4.5) 1.3(0.6)
ND25-50 kcal d- 9 0 1.0(1.5) 4.2(6.0) 2.1(0.7)f
ND25-35 kcal d- 10 0 1.7(2.2) 1.7(2.2) 1.3(0.8)
Group 3 ND45-50 kcal d-' 12 1.2(0.5) 0.5(0.8) 0.08(0.2) 0.5(0.6)
(HPC) ND45-35 kcal d-' 7 1.5(0.7) 0.8(0.1) 0.06(0.1) 0.3(0.6)
ND35-50 kcal d- 13 1.5(l.1) 0.5(0.3) 0.1 (0.1) 0.5(0.8)
ND35-35 kcal d- 9 1.7(1.3) 0.2(0.7) 0.05(0.1) 0.4(0.6)
ND25-50kcald' 18 1.6(1.0) 0.2(0.7) 0.3 (0.8) 0.6(0.5)
ND25-35 kcal d' 8 1.5(0.7) 0.2(0.3) 0.004(0.001) 0.6(0.5)
an = Numberofanimals atterminationofstudy,bND = normal-Diet,percentageof
total energy: 45%, 35%, 25%, 'mean (standard deviation), dp = 0.01, significant
difference between the tumourvolumes ofallhighcaloric groups versus the respective
lowcaloric groups, cp = 0.04, fP = 0.06, marginally significant difference between the
tumour numbers ofall high caloric groups versus the respective low caloric groups,
gtime ofdietary change, hweeks after dietary change, 'termination of experiment.
Recurrence rates oftumours after surgical removal
The influence of dietary fat and calorie intake on the recur-
rence of tumours after surgical removal is shown in Table V.
No significant differences in the recurrence rates of tumours
were found between the three fat concentrations or between
the two calorie levels except a greater recurrence rate in
animals ingesting 50 kcal of the lowest fat diet.
Oestradiol (E2) and testosterone inplasma
Plasma levels of oestradiol and testosterone measured after
termination of the experiment are shown in Table VI. After
chemotherapeutic treatment (Group 3-HPC) a significant in-
crease (P = 0.04, Wilcoxon rank sum test; test statistics
= 707.00) in oestradiol levels was found in all high calorie
groups in comparison with restrictively fed groups, irrespec-
tive of the fat level. Similar trends were observed in the other
two groups, but these differences were not statistically
significant. No differences in oestradiol levels were found
among the three fat concentrations.
Testosterone levels in plasma were not significantly influ-
enced by calorie changes. In the control group animals fed
45% fat had significantly (P<0.05, Kruskal Wallis test; test
statistics = 8.49) higher testosterone levels than those fed
35% fat. This difference could, however, not be observed in
the treated groups (OP and HPC). Additionally, testosterone
values of surgically treated animals were generally higher
Table V Influence of different fatty acids and caloric levels on the
recurrence of tumours after surgical removal
Recurrence of
Diet (kcald-') na tumoursb
OP-Group ND345-50 kcal d- i 11 1/11 (9.1%)d
ND45-35 kcal d' 10 3/10(30.0%)
ND35-50 kcal d' 12 3/12(25.0%)
ND35-35 kcal d-' 10 3/10(30.0%)
ND25-50 kcal d- 9 6/ 9(66.7%)d
ND45-35 kcal d- 10 2/10(20.0%)
aNumber of animals at termination of study, bnumber (per cent) of
recurrences, cNormal-Diet, percentage of energy: 45%, 35%, 25%, dp<0.01, significantdifferencebetween thehighcalorielevels ofgroups
ND45 and ND25.
than those of untreated tumour-bearing animals (control
group). This difference was significant (P = 0.0000, Wilcoxon
test; test statistics = 4838.00) when all surgically treated ani-
mals were compared with all animals of the control group,
irrespective of fat content and calorie level.
Discussion
Previous studies have demonstrated that reduced food intake
during tumourigenesis results in a reduction of tumour
TableVI Influence ofdifferentfattyacidsandcaloriclevelsonplasma
oestradiol- and testosterone-levels in rats bearing MNU-induced
mammary carcinomas at the end ofexperiment.
Diet (kcalld-')
Group 1 NDb45-50 kcald'-I
(CO) ND45-35 kcal d-'
ND35-50 kcal d-'
ND35-35 kcal d-'
ND25-50 kcal d-'
ND25-35 kcal d-'
Group 2 ND45-50 kcal d-'
(OP) ND45-35 kcal d-'
ND35-50 kcal d-'
ND35-35 kcal d-'
ND25-50 kcal d-'
ND25-35 kcal d-'
Group 3 ND45-50 kcal d-'
(HPC) ND45-35 kcal d-'
ND35-50 kcal d-'
ND35-35 kcal d-'
ND25-50 kcal d-'
ND25-35 kcal d-'
na
13
12
11
10
8
11
11
10
12
10
9
10
12
7
13
9
18
8
Oestradiol (E2) Testosterone
(pgml-') (pgml-')
7.0 (7.2)c) 97.7 (84.6)e.f
9.7 (9.0) 73.5 (38.0)eCf 5.0 (0.0) 72.1 (84.7)ef
5.0 (0.0) 40.0 (O-.l)e,f
6.0 (2.8) 60.9 (27.2)e
5.6 (1.0) 51.1 (26.6)e
13.9(17.9)
5.7 (2.2)
6.0 (2.6)
5.0 (0.0)
6.9 (4.3)
6.8 (4.4)
13.7(14.7)d
8.1 (5.8)
8.5 (8.3)d
5.0 (0.0)
1 1.7(12.0)d
5.0 (0.0)
157.0(144.5)e
160.0(106.1)C
139.4 (80.1)e
87.8 (44.7)e
118.8 (68.1)e
90.4 (43.8)c
152.3(210.3)
76.7 (48.6)
64.0 (57.7)
52.0 (27.6)
92.1 (79.0)
103.3(125.0)
aNumber ofanimals, bNormal-Diet, percentage ofenergy: 45%, 35%,
25%, cmean (standard deviation), dP<0.05, significant difference
between the oestradiol levels of all high caloric groups versus the
respective low caloric groups, ep<0.05, significant difference between
the testosterone levels of all animals of group 1 versus all animals of
group 2, fP<0.05, significant difference between the testosterone levels
ofall animalsofgroupsfed45% and 33% fat, irrespective ofthecalorie
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growth both in hormone-dependent (Cohen et al., 1988; Krit-
chevsky et al., 1986; Pollard et al., 1989) and hormone-
independent tumours (Gross 1988; Pollard et al., 1989). In
this study we investigated the influence of dietary luxury
calories at three different fat levels on the growth of manifest
MNU-induced mammary carcinomas, on the regrowth of
these lesions after surgical removal as well as on the anti-
neoplastic efficacy of the new cytostatic agent HPC in these
tumours. Furthermore, we determined plasma oestradiol and
testosterone levels at the end of the experiment. Our data
show that, even after manifestation of chemically induced
mammary carcinomas, a reduction of luxury calories (30%
calorie restriction) significantly inhibited tumour growth,
irrespective of the fat level. No significant differences in
tumour growth were observed when the three fat concentra-
tions were compared. After surgical treatment of the animals,
reduction of calories led to remarkable (but not significant)
inhibition of tumour growth. Again, the fat content had no
influence on the regrowth of tumours. After chemothera-
peutic treatment, reduction of neither fat intake nor calorie
intake produced additional significant effects on tumour
development. These results are in agreement with studies by
other authors, who reported on retarded tumour growth and
prolonged survival of tumour-bearing rats after restricted
food intake. However, there is only scarce information of
dietary influences on tumour growth after manifestation of
tumours. By feeding semisynthetic diets with a fatty acid
composition reflecting the fatty acid profile of the normal
West German diet we used diets adapted more to the human
situation than it has been described by other authors (Jose &
Good, 1973). Unlike Sandor (1976) who subjected male mice
to different schedules of fasting and found a significant
tumour retardation, we only tried to avoid 'luxury calories'
leading to body fat accumulation and high spontaneous
tumor incidence in rodents (Roe, 1981), and not to subject
the animals to periods of starvation since fasting can also
stimulate tumour growth (Sauer et al., 1986). Siegel et al.
(1988) found a significantly enhanced survival of mammary
ascites tumour bearing rats after 'mild dietary restrictions'
(ad libitum feeding followed by alternate fasting), and sug-
gested on the basis of their data that relatively 'mild dietary
restrictions' should be included in clinical trials designed to
inhibit cancer growth and enhance the survival of human
cancer patients. How 'mild dietary restrictions' in the form of
ad libitum feeding followed by alternate fasting can be
adapted to the human situation remains open.
Surgical removal of tumours at a size of 1 cm3 followed by
reduction of luxury calories led to an almost significant
inhibition of new tumour growth but not to a decreased
recurrence rate of tumours in our study. Animals ingesting
50 kcal of the lowest fat diet unexpectedly showed a greater
recurrence rate than all other groups. This observation can
probably be considered a chance association due to the small
number of animals in this group. The former finding con-
trasts to a study by Donegan et al. (1978) who found that the
recurrence of breast carcinomas after radical mastectomy was
associated with high preoperative body weight: Women with
the highest risk of treatment failure weighed in excess of 170
pounds. An explanation for the only mild effect of dietary
changes after surgical tumour removal in our study could be
that biochemical changes, induced by surgery (Eisele, 1986),
suppressed effects caused by calorie restriction. One piece of
evidence supporting this assumption is the generally in-
creased testosterone level in animals of this group.
Chemotherapeutically treated animals subjected to reduced
fat and/or calorie intake showed no significant additional
retardation of tumour growth in comparison to chemothera-
peutically treated animals fed ad libitum. Daly et al. (1980)
demonstrated that chemotherapy with methotrexate (MTX)
was maximally effective in tumour-bearing rats when they
were switched from a protein-free diet to a regular diet, i.e.,
that nutritional manipulation can increase tumour response
to chemotherapy. HPC, which belongs to the group of ether
lipids, was as effective as surgical removal of manifest mam-
mary carcinomas (Berger et al., 1987). We therefore decided
to choose this membrane directed cytostatic agent for trea-
ting MNU-induced mammary carcinomas in our study assu-
ming a considerable regrowth of lesions after the end of the
therapy. However, HPC exerted a high antineoplastic effect
on MNU-induced mammary carcinomas, lasting even after 5
weeks without treatment, which prevented detection of more
than minimal numerical differences between high and low
calorie fed groups. It is interesting to note, however, that the
observed differences in tumour growth and tumour number
at the end of dietary treatment were all in favour of the low
calorie groups (Table IV), indicating that a less effective
chemotherapy could be basis of a more distinct difference.
With the exception of chemotherapeutically treated ani-
mals, neither reduction of fat content nor reduction ofcalorie
intake significantly altered estradiol levels in plasma at the
stage of diestrus of the oestrous cycle. Our results are in
agreement with the studies by Wetsel et al. (1984) and Hop-
kins et al. (1981) who did not find a relationship between
dietary fat content and ovarian hormone secretion. Ip & Ip
(1981) found significantly lower serum oestradiol levels in
DMBA-treated rats fed 0.5% corn oil compared with rats fed
20% corn oil, but no differences between groups fed more
realistic fat levels of 5% and 20% corn oil. In an experiment-
al study by Chan et al. (1977) only in the stage of meto-
estrus-dioestrus total serum oestrogens were significantly
higher in MNU-treated rats fed 20% lard than in rats fed
5% lard, the effect of dietary fat on oestrogen concentration,
however, did not appear to be related to breast cancer.
Unlike the studies mentioned above in which rats were fed
diets containing corn oil or lard, we tried to adapt the diets
and the feeding regimen to a situation comparable to the
human situation.
In our study, only animals treated with HPC and fed a
high calorie diet had significantly higher oestradiol levels
than animals on a low-calorie diet, irrespective of the fat
level. The precise mode of the tumour inhibiting action of
HPC, is not yet fully understood (Hilgard et al., 1988).
Inhibitory effects of ET-18-OHC3, another ether lipid, on
oestradiol uptake into the human breast cancer MCF-7 cells
have recently been described (Kosano et al., 1990). The
question whether ether lipids, especially HPC, influence end-
ocrine parameters in vivo has not yet been answered.
Testosterone levels were not significantly influenced by the
different fat or calorie levels of the diets.
In summary, we have demonstrated that reduction of
calories by 30% significantly inhibited tumour growth of
manifest MNU-induced mammary carcinomas, irrespectively
of the fat levels. Compared to the effects of surgical and
chemotherapeutic treatment, the additional influence of die-
tary changes was less important, but contributed - in sur-
gically treated animals to a considerable degree - to the
desired outcome of therapy. An association of mammary
tumour growth and sexual hormone secretion could not be
observed. Extrapolation of our findings to humans suggests
that dietary measures complementary to the usual clinical
treatment of mammary carcinomas are of differential rele-
vance, but that mild dietary restrictions could be able to
inhibit further tumour development and thus may play a role
in the prevention of further tumour growth in patients. The
precise mechanisms of the tumour-inhibiting effect of energy
restriction remain to be elucidated.
The authors thank M. Bucur, A. Danisman, M. Konig and A.
Weninger for their careful technical assistance.850 B. BUNK et al.
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